Poster featuring TILT technology will be presented at the European Society of Cell and Gene Therapy Annual Congress in Florence, Italy in October 2016.
A fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy
Latest News
Upcoming Events
Please contact our business development team to meet us at the following events:
17-19th September 2024
Nordic Life Science Days (NLSDays)
Malmö, Sweden
27-30th October 2024
16th Annual International Oncolytic Virotherapy Conference
Rotterdam, Netherlands
4-6th November 2024
BIO-Europe
Stockholm, Sweden
20-21st November 2024
SLUSH
Helsinki, Finland
11-13th December 2024
ESMO Immuno-Oncology Congress
Geneva, Switzerland
13-15th January 2025
Biotech Showcase
San Francisco (CA), USA